PeptideDB

SARS-CoV-IN-1 888958-25-6

SARS-CoV-IN-1 888958-25-6

CAS No.: 888958-25-6

SARS-CoV-IN-1 is a potent inhibitor of SARS-CoV replication. In Vero cells, SARS-CoV-IN-1 is antiviral with EC50 of 4.9
Data collection:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

SARS-CoV-IN-1 is a potent inhibitor of SARS-CoV replication. In Vero cells, SARS-CoV-IN-1 is antiviral with EC50 of 4.9 μM. SARS-CoV-IN-1 inhibits P. falciparum 3D7 and W2 strains with IC50s of 15.4 and 133.2 nM respectively; IC90s of 25.7 and 459.1 nM respectively. Has antimalarial and anti-viral effect.

Physicochemical Properties


Molecular Formula C23H24CLFEN3O
Molecular Weight 441.70
CAS # 888958-25-6
Appearance Light yellow to yellow solid powder
Synonyms

SARSCoVIN1; SARS CoV IN 1
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


ln Vitro In vitro, SARS-CoV-IN-1 (compound 2) inhibits Plasmodium falciparum development significantly more effectively than chloroquine (CQ) [1].
References

[1]. Design and synthesis of hydroxyferroquine derivatives with antimalarial and antiviral activities. J Med Chem. 2006 May 4;49(9):2845-9.


Solubility Data


Solubility (In Vitro) DMSO : ~41.67 mg/mL (~94.34 mM)
Solubility (In Vivo) Solubility in Formulation 1: ≥ 4.17 mg/mL (9.44 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 41.7 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

Solubility in Formulation 2: ≥ 4.17 mg/mL (9.44 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 41.7 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 2.2640 mL 11.3199 mL 22.6398 mL
5 mM 0.4528 mL 2.2640 mL 4.5280 mL
10 mM 0.2264 mL 1.1320 mL 2.2640 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.